Jinzhong Xu1,2, Hui Li3,4, Fan Wang3,5, Zeping Xu2, Guohua Li3, Cheng Ding6, Junnan Wu2, Yimin Kang4, Hong Li7, Heng Xu8,9, Yanlong Liu10. 1. The Affiliated Wenling Hospital of Wenzhou Medical University, Wenling, 317500, China. 2. College of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325035, China. 3. Second Affiliated Hospital of Xinjiang Medical University, Urumqi, 830028, China. 4. Psychosomatic Medicine Research Division, Inner Mongolia Medical University, Huhhot, 010110, China. 5. Beijing Hui-Long-Guan Hospital, Peking University, Beijing, 100096, China. 6. Department of Respiratory Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325035, China. 7. Department of General Surgery, Ningbo Medical Treatment Center, Li Huili Hospital, Ningbo, 315000, China. 8. Second Affiliated Hospital of Xinjiang Medical University, Urumqi, 830028, China. changshengx@126.com. 9. The Second Xiangya Hospital, Central South University, Changsha, 410011, China. changshengx@126.com. 10. College of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325035, China. benjaminlyl@wmu.edu.cn.
Abstract
OBJECTIVE: Glutamate is an excitatory neurotransmitter in the central nervous system that participates in initiation and maintenance of sleep and wakefulness. The mechanisms involved occur in the brainstem, lateral hypothalamus, and basal forebrain. Our previous study suggested that higher levels of glutamate in cerebrospinal fluid (CSF) contributed to poorer sleep quality. Smoking has been shown to be harmful to sleep quality. In the present study, we recruited non-smokers and heavy smokers and measured the concentration of CSF glutamate in order to investigate the associations among smoking status, sleep quality, and CSF glutamate levels. METHODS: We recruited 147 men (n = 68 non-smokers, 30.31 ± 9.10 years; n = 79 heavy smokers, 34.54 ± 10.71 years). Glutamate concentrations in CSF were measured by spectrophotometry, and subjective sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI). RESULTS: PSQI total scores were significantly higher in heavy smokers than that in non-smokers (p < 0.001). Glutamate concentrations in CSF were lower in heavy smokers than that in non-smokers (p < 0.001). CSF glutamate levels positively correlated with PSQI total scores in the non-smokers group (r = 0.313, p = 0.011, effect size = 0.324). No correlation was found between CSF glutamate levels and PSQI total scores in the heavy smokers group (p > 0.05). Multivariable linear regression analysis showed that years of smoking was contributed to the PSQI total scores (p = 0.008), and cigarettes smoked per day contributed to the decreased CSF glutamate levels in heavy smokers (p = 0.001). CONCLUSION: Poorer subjective sleep quality and lower CSF glutamate concentrations were observed in the heavy smokers group than in the non-smokers group. In addition, lack of correlation was observed between CSF glutamate levels and PSQI scores in the heavy smokers.
OBJECTIVE:Glutamate is an excitatory neurotransmitter in the central nervous system that participates in initiation and maintenance of sleep and wakefulness. The mechanisms involved occur in the brainstem, lateral hypothalamus, and basal forebrain. Our previous study suggested that higher levels of glutamate in cerebrospinal fluid (CSF) contributed to poorer sleep quality. Smoking has been shown to be harmful to sleep quality. In the present study, we recruited non-smokers and heavy smokers and measured the concentration of CSF glutamate in order to investigate the associations among smoking status, sleep quality, and CSF glutamate levels. METHODS: We recruited 147 men (n = 68 non-smokers, 30.31 ± 9.10 years; n = 79 heavy smokers, 34.54 ± 10.71 years). Glutamate concentrations in CSF were measured by spectrophotometry, and subjective sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI). RESULTS: PSQI total scores were significantly higher in heavy smokers than that in non-smokers (p < 0.001). Glutamate concentrations in CSF were lower in heavy smokers than that in non-smokers (p < 0.001). CSF glutamate levels positively correlated with PSQI total scores in the non-smokers group (r = 0.313, p = 0.011, effect size = 0.324). No correlation was found between CSF glutamate levels and PSQI total scores in the heavy smokers group (p > 0.05). Multivariable linear regression analysis showed that years of smoking was contributed to the PSQI total scores (p = 0.008), and cigarettes smoked per day contributed to the decreased CSF glutamate levels in heavy smokers (p = 0.001). CONCLUSION: Poorer subjective sleep quality and lower CSF glutamate concentrations were observed in the heavy smokers group than in the non-smokers group. In addition, lack of correlation was observed between CSF glutamate levels and PSQI scores in the heavy smokers.
Entities:
Keywords:
Cerebrospinal fluid; Glutamate; Heavy smoking; Sleep
Authors: Hyung W Nam; Sally R McIver; David J Hinton; Mahesh M Thakkar; Youssef Sari; Fiona E Parkinson; Phillip G Haydon; Doo-Sup Choi Journal: Alcohol Clin Exp Res Date: 2012-02-06 Impact factor: 3.455
Authors: Joseph P H McNamara; Jiantong Wang; David B Holiday; Jessica Young Warren; Marilyn Paradoa; Amanda Marie Balkhi; Jeannette Fernandez-Baca; Christina S McCrae Journal: Psychol Health Med Date: 2013-09-17 Impact factor: 2.423
Authors: Helton J Reis; Cristina Guatimosim; Maryse Paquet; Magda Santos; Fabíola M Ribeiro; Arthur Kummer; Grace Schenatto; João V Salgado; Luciene B Vieira; Antônio L Teixeira; András Palotás Journal: Curr Med Chem Date: 2009 Impact factor: 4.530
Authors: Mhj Schulte; A E Goudriaan; A M Kaag; D P Kooi; W van den Brink; R W Wiers; L Schmaal Journal: J Psychopharmacol Date: 2017-09-19 Impact factor: 4.153
Authors: Pearlynne L H Chong; Dea Garic; Mark D Shen; Iben Lundgaard; Amy J Schwichtenberg Journal: Sleep Med Rev Date: 2021-11-18 Impact factor: 11.609